Chronic Obstrutive Pulmonary Disease
Conditions
Interventions
Treatment Group:Conventional Therapy+Chuankezhi Injection
Control Group:Conventional Therapy
Sponsors
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Sign informed consent; 2. Aged 40~80 years old, male or female; 3. Accord with diagnostic criteria for COPD at stable phase; 4. COPD patients at II~IV stage; 5. Accord with diagnostic criteria for lung and kidney dificiency syndrome in TCM.
Exclusion criteria
Exclusion criteria: 1. Be allergic to ingredients of the study medicine or allergic constitution patients; 2. Patients who need long-term hormone treatment; 3. COPD due to lacking of a1-antitrypsin, unhealthy development of lung; 4. Combined with obstructive lung diseases which have known pathogen such as pulmonary cystic fibrosis, diffuse panbronchiolitis, and blocking panbronchiolitis or have characteristic pathological feature; 5. Combined with severe primary diseases in vital organs or systems such as heart, lung, kidney, hemopoietic system; 6. ALTAST=1.5 times of upper limit of normal value, Cr> upper limit of normal value; 7. Be suspicious of or confirmed to have alcohol or drug abuse history, or other circumstances that may lower the enrollment possibility or complicate enrollment according to researchers; 8. Combined with nerve or mental diseases that make cooperation difficult; 9. Pregnant, lactating women or with family planning recently; 10. Undergoing other clinical trial or less than 3 month since the last clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Times of COPD Acute Attack and Hospitalization; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM Syndrome;BODE Index;Life Quality; | — |
Countries
China
Contacts
Public ContactLiu Xiaohong
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed